4/21, 5:10 AM (Source: TeleTrader)
more TeleTrader news

Fujifilm begins Phase III trial of Avigan's use for COVID

Fujifilm Holdings Corp. announced on Wednesday that it started a phase III clinical trial related to the use of the anti-influenza drug Avigan in the treatment of coronavirus infections.

The process will focus on patients, aged 50 and older, with early-onset COVID-19 which are at risk factors of developing severe symptoms, the company said.

Fujifilm added that it applied for approval of Avigan after the drug showed a "statistically significant difference" when it came to improving the patients' condition during the trial.

Breaking the News / MD